DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Striepe K, Jumar A, Ott C. et al
Effects of the selective sodium-glucose cotransporter 2 inhibitor empagliflozin on vascular function and central hemodynamics in patients with zype 2 diabetes mellitus.
Circulation 2017;
136: 1167-1169 . doi:10.1161/CIRCULATIONAHA.117.029529
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.